Patents by Inventor Allen Wayne Mangel

Allen Wayne Mangel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040192694
    Abstract: The invention provides a COX-2 inhibitor or a pharmaceutically acceptable derivative thereof for use in the treatment of a disorder ameliorated by a gastroprokinetic.
    Type: Application
    Filed: February 25, 2004
    Publication date: September 30, 2004
    Inventors: Allen Wayne Mangel, Alan Naylor
  • Patent number: 6759413
    Abstract: The invention provides a COX-2 inhibitor or a pharmaceutically acceptable derivative thereof for use in the treatment of a disorder ameliorated by a gastroprokinetic.
    Type: Grant
    Filed: July 25, 2002
    Date of Patent: July 6, 2004
    Assignee: SmithKline Beecham Corporation
    Inventors: Allen Wayne Mangel, Alan Naylor
  • Publication number: 20040072848
    Abstract: The present invention relates to the use of certain glycol derivatives of xanthines for the treatment of irritable bowel syndrome and functional dyspepsia.
    Type: Application
    Filed: August 7, 2003
    Publication date: April 15, 2004
    Inventors: Brian E Huber, Allen Wayne Mangel
  • Publication number: 20030187017
    Abstract: This invention relates to the use of alosetron in the treatment or functional dyspepsia.
    Type: Application
    Filed: November 14, 2002
    Publication date: October 2, 2003
    Inventor: Allen Wayne Mangel
  • Patent number: 6593336
    Abstract: This invention relates to the use of 5-HT3 receptor antagonists in the treatment of nonconstipated female IBS patients.
    Type: Grant
    Filed: June 10, 2002
    Date of Patent: July 15, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Allen Wayne Mangel, Allison Ruth Northcutt
  • Publication number: 20030036549
    Abstract: This invention relates to the use of 5-HT3 receptor antagonists in the treatment of nonconstipated female IBS patients.
    Type: Application
    Filed: June 10, 2002
    Publication date: February 20, 2003
    Inventors: Allen Wayne Mangel, Allison Ruth Northcutt
  • Publication number: 20030022897
    Abstract: The invention provides a COX-2 inhibitor or a pharmaceutically acceptable derivative thereof for use in the treatment of a disorder ameliorated by a gastroprokinetic.
    Type: Application
    Filed: July 25, 2002
    Publication date: January 30, 2003
    Inventors: Allen Wayne Mangel, Alan Naylor
  • Patent number: 6429209
    Abstract: This invention relates to the use of 5-HT3 receptor antagonists in the treatment of nonconstipated female IBS patients.
    Type: Grant
    Filed: April 13, 2001
    Date of Patent: August 6, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Allen Wayne Mangel, Allison Ruth Northcutt
  • Publication number: 20010044450
    Abstract: This invention relates to the use of 5-HT3 receptor antagonists in the treatment of nonconstipated female IBS patients.
    Type: Application
    Filed: April 13, 2001
    Publication date: November 22, 2001
    Inventors: Allen Wayne Mangel, Allison Ruth Northcutt
  • Patent number: 6284770
    Abstract: This invention relates to the use of 5-HT3 receptor antagonists in the treatment of nonconstipated female IBS patients.
    Type: Grant
    Filed: April 5, 2000
    Date of Patent: September 4, 2001
    Assignee: Glaxo Wellcome Inc.
    Inventors: Allen Wayne Mangel, Allison Ruth Northcutt